Matches in Wikidata for { <http://www.wikidata.org/entity/Q82485474> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- Q82485474 description "2011 թվականի նոյեմբերի 11-ին հրատարակված գիտական հոդված" @default.
- Q82485474 description "article scientifique publié en 2011" @default.
- Q82485474 description "artículu científicu espublizáu en payares de 2011" @default.
- Q82485474 description "scientific article published on 11 November 2011" @default.
- Q82485474 description "wetenschappelijk artikel" @default.
- Q82485474 description "наукова стаття, опублікована в листопаді 2011" @default.
- Q82485474 name "Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial" @default.
- Q82485474 name "Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial" @default.
- Q82485474 type Item @default.
- Q82485474 label "Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial" @default.
- Q82485474 label "Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial" @default.
- Q82485474 prefLabel "Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial" @default.
- Q82485474 prefLabel "Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial" @default.
- Q82485474 P1433 Q82485474-29C40528-9AE0-4EC9-A532-1F0B338518D3 @default.
- Q82485474 P1476 Q82485474-D116CA6C-950A-4600-A084-8AC0E0FAFFB2 @default.
- Q82485474 P2093 Q82485474-2356B2FB-E5D6-4144-91BE-C890C05B6B11 @default.
- Q82485474 P2093 Q82485474-2B220925-9806-4657-BA63-DEC56F44BB34 @default.
- Q82485474 P2093 Q82485474-405776E2-C9F9-4CF5-926D-44D7E29EDAA5 @default.
- Q82485474 P2093 Q82485474-426ECA58-0712-47F8-BA4B-4E82703ACE88 @default.
- Q82485474 P2093 Q82485474-823990B1-8E36-4B7E-AEA1-2EB687A0F4B1 @default.
- Q82485474 P2093 Q82485474-8C48F92C-C273-4839-8C8C-AEEB9DFD754B @default.
- Q82485474 P2093 Q82485474-AA3083DE-16F6-4F76-BDD2-560699A6916C @default.
- Q82485474 P2093 Q82485474-C07DE25C-FC20-4DE5-9E62-B38D4E3CFCFC @default.
- Q82485474 P2093 Q82485474-CEBE5CE3-1B57-4D0C-86C8-8D39BBBE2963 @default.
- Q82485474 P2093 Q82485474-D003251B-26D2-4240-A858-2B414BF30285 @default.
- Q82485474 P2093 Q82485474-D4C6E446-7E86-4970-923A-FC598925EF40 @default.
- Q82485474 P2093 Q82485474-DA9769CC-C6A7-4279-8814-371B7B6DD99D @default.
- Q82485474 P2093 Q82485474-F64C8940-304D-4B0A-9053-20137D0F86E0 @default.
- Q82485474 P304 Q82485474-AB66744D-BBAE-4915-B726-1873D38EEDE5 @default.
- Q82485474 P31 Q82485474-4ADD37FC-9DEB-41AE-A8D8-D63EC306F1DF @default.
- Q82485474 P356 Q82485474-744117DE-4CAD-4452-83E6-BB47DB566141 @default.
- Q82485474 P433 Q82485474-CF01D709-5526-43D3-97E3-A5E0C8F824D0 @default.
- Q82485474 P478 Q82485474-8FEAF78D-B67A-410C-B4FB-FBAB50147856 @default.
- Q82485474 P50 Q82485474-659F3A4C-943E-4476-A72E-47A440BEB8CB @default.
- Q82485474 P50 Q82485474-8D1C2A57-3F0B-4DA4-85CD-BBB83E43A00E @default.
- Q82485474 P577 Q82485474-7C7BF362-A561-487E-A20D-3BFC648A753C @default.
- Q82485474 P698 Q82485474-262F09D3-494A-424E-91E9-611A525FFF1F @default.
- Q82485474 P921 Q82485474-062E2D45-5DFE-432C-9C07-6DE5FA2D15AC @default.
- Q82485474 P921 Q82485474-26E6C73A-9AAF-46FA-BD95-C247F380725F @default.
- Q82485474 P921 Q82485474-C19F257A-C895-4A5A-A022-65B4F275478A @default.
- Q82485474 P356 J.IJROBP.2011.06.2008 @default.
- Q82485474 P698 22079731 @default.
- Q82485474 P1433 Q2296252 @default.
- Q82485474 P1476 "Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial" @default.
- Q82485474 P2093 "Ana Chopitea" @default.
- Q82485474 P2093 "Javier Rodríguez" @default.
- Q82485474 P2093 "Jesús García-Foncillas" @default.
- Q82485474 P2093 "Jesús Javier Sola" @default.
- Q82485474 P2093 "Jorge Nuñez" @default.
- Q82485474 P2093 "Jose Carlos Subtil" @default.
- Q82485474 P2093 "Jose Luis Hernández" @default.
- Q82485474 P2093 "Juan A Díaz-González" @default.
- Q82485474 P2093 "Leire Arbea" @default.
- Q82485474 P2093 "Luis Isaac Ramos" @default.
- Q82485474 P2093 "Marta Moreno" @default.
- Q82485474 P2093 "Miren Gaztañaga" @default.
- Q82485474 P2093 "Rafael Martínez-Monge" @default.
- Q82485474 P304 "587-593" @default.
- Q82485474 P31 Q13442814 @default.
- Q82485474 P356 "10.1016/J.IJROBP.2011.06.2008" @default.
- Q82485474 P433 "2" @default.
- Q82485474 P478 "83" @default.
- Q82485474 P50 Q63866140 @default.
- Q82485474 P50 Q74434079 @default.
- Q82485474 P577 "2011-11-11T00:00:00Z" @default.
- Q82485474 P698 "22079731" @default.
- Q82485474 P921 Q420207 @default.
- Q82485474 P921 Q422327 @default.
- Q82485474 P921 Q42824440 @default.